AEON Biopharma, Inc.
Q4 2023 13F Holders
Symbol
AEON
CUSIP
00791X100
Type
Equity
Class
CL A
Num filings
25
Total reported value, excl. options
$57.0 M
Compare 2023 Q4 to
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q3
Manager
Report Date
Value ($000)
Shares
Option Type